View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0650
ICR Reference No:
202412-0910-013
Status:
Active
Previous ICR Reference No:
202303-0910-009
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CTP
Title:
Tobacco Product Establishment Registration and Submission of Certain Health Information
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
04/07/2026
Retrieve Notice of Action (NOA)
Date Received in OIRA:
09/15/2025
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
04/30/2029
36 Months From Approved
04/30/2026
Responses
1,397
0
3,258
Time Burden (Hours)
520
0
962
Cost Burden (Dollars)
0
0
0
Abstract:
The Federal Food, Drug, and Cosmetic Act (FD&C Act), amended by the Tobacco Control Act of 2009, grants FDA the authority to regulate the manufacture, marketing, and distribution of tobacco products to protect the public health generally and to reduce tobacco use by minors. Section 905 of the FD&C Act requires the annual registration of any establishment in any State engaged in the manufacture, preparation, compounding, or processing of a tobacco product or tobacco products. Section 904 of the FD&C Act requires that each tobacco product manufacturer or importer submit a listing of all ingredients and additives that are added by the manufacturer to each tobacco product by brand and by quantity in each brand and sub brand. Section 904 also requires that a tobacco product manufacturer advise the FDA in writing prior to adding any new tobacco additive or increasing in quantity an existing tobacco additive. It also requires that a tobacco product manufacturer advise the FDA in writing prior to eliminating or decreasing an existing additive, or adding or increasing an additive designated by the FDA as not a human or animal carcinogen, or otherwise harmful to health under intended conditions of use.
Authorizing Statute(s):
US Code:
21 USC 905
Name of Law: FFDCA
US Code:
21 USC 904
Name of Law: FFDCA
PL:
Pub.L. 111 - 111 31
Name of Law: Family Smoking Prevention and Tobacco Control Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
90 FR 5909
01/17/2025
30-day Notice:
Federal Register Citation:
Citation Date:
90 FR 43455
09/09/2025
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
6
IC Title
Form No.
Form Name
Establishment Registration (Initial), the initial registration of a tobacco product establishment
FDA 3741 , FDA 3741a , FDA 3741
(Current) Registration and Listing for Owners and Operators of Domestic Tobacco Product Establishments
,
(Current) Registration and Listing for Owners and Operators of Domestic Deemed Tobacco Product Establishments
,
(New) Registration and Listing for Owners and Operators of Domestic Tobacco Product Establishments
Establishment Registration (Renewal), the registration renewal of a tobacco product establishment
FDA 3471 (Current), FDA 3741a (Current), FDA 3741 (New)
Registration and Listing for Owners and Operators of Domestic Tobacco Product Establishments
,
Registration and Listing for Owners and Operators of Domestic Deemed Tobacco Product Establishments
,
Registration and Listing for Owners and Operators of Domestic Deemed Tobacco Product Establishments
Obtaining a Dun and Bradstreet D-U-N-S Number
Product Listing (Initial), the initial listing of tobacco products (New) Form FDA 3741b, "Tobacco Product List Spreadsheet"
FDA 3741b
Tobacco Product List Spreadsheet
Tobacco Product Listing Form FDA 3742, "Listing of Ingredients in Tobacco Products" Section 904(a)(1)
FDA 3742
Listing of Ingredients in Tobacco Products
Tobacco Product Listing Form FDA 3742, "Listing of Ingredients" Section 904(c)
FDA 3742, eSubmitter; FDA Form 3742 , eSubmitter; FDA Form 3742
Tobacco Product Ingredients Importer form
,
Tobacco Ingredients Manufacturer
,
Tobacco Ingredients Importer
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
1,397
3,258
0
0
-1,861
0
Annual Time Burden (Hours)
520
962
0
0
-442
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Based on the combined impacts of program changes and adjustments, our estimated burden for the information collection reflects an overall decrease of 442 annual burden hours and a decrease of 1,861 annual responses.
Annual Cost to Federal Government:
$2,122,208
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
09/15/2025
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.